Atossa Therapeutics, Inc. (ATOS)

Atossa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	31.72	41.3	71.08	88.46	110.89	136.38
Cash & Short-Term Investments	31.72	41.3	71.08	88.46	110.89	136.38
Cash Growth	-51.29%	-41.90%	-19.64%	-20.23%	-18.69%	244.79%
Other Receivables	-	-	-	-	0.74	1.07
Total Trade Receivables	-	-	-	-	0.74	1.07
Other Current Assets	4.95	4.32	3.37	3.76	6.56	3.79
Total Current Assets	36.67	45.62	74.46	92.22	118.2	141.24
Long-Term Investments	-	-	-	1.71	4.7	-
Other Long-Term Assets	1.28	1.99	1.99	2.32	0.64	0.02
Total Assets	37.94	47.61	76.44	96.25	123.53	141.26
Accounts Payable	2.57	4.29	0.68	0.81	2.97	1.72
Accrued Expenses	3.75	2.87	2.78	2.63	2.58	1.39
Other Current Liabilities	1.14	1.1	1.51	1.8	0.02	0.02
Total Current Liabilities	7.46	8.26	4.97	5.24	5.57	3.13
Total Liabilities	7.46	8.26	4.97	5.24	5.57	3.13
Common Stock	1.55	1.55	1.55	22.79	22.79	22.79
Treasury Stock	-1.48	-1.48	-1.48	-1.48	-	-
Additional Paid-in Capital	286.56	285.84	283.19	255.99	251.37	244.58
Retained Earnings	-256.15	-246.56	-211.79	-186.29	-156.19	-129.23
Shareholders' Equity	30.49	39.35	71.48	91.02	117.96	138.14
Total Liabilities & Equity	37.94	47.61	76.44	96.25	123.53	141.26
Net Cash (Debt)	31.72	41.3	71.08	88.46	110.89	136.38
Net Cash Growth	-23.20%	-41.90%	-19.64%	-20.23%	-18.69%	244.94%
Net Cash Per Share	3.68	4.80	8.47	10.52	13.14	17.49
Book Value	30.49	39.35	71.48	91.02	117.96	138.14
Book Value Per Share	3.54	4.57	8.52	10.83	13.97	17.72
Tangible Book Value	30.49	39.35	71.48	91.02	117.96	138.14
Tangible Book Value Per Share	3.54	4.57	8.52	10.83	13.97	17.72

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q